Skip to main content

4 Result(s)

within Bertrand Lukacs Remove this filter

and

  1. No Access

    Chapter

    How the SNIIRAM–PMSI Database Enables the Study of Surgical Practices

    Medical progress is based in part on the results of client-controlled studies, the best model of which is a double-blind randomized study testing a new treatment compared with a treatment with already-known ef...

    Bertrand Lukacs in Healthcare and Artificial Intelligence (2020)

  2. Article

    Open Access

    Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality

    This very large population-based study investigated outcomes after a diagnosis of prostate cancer (PCa) in terms of mortality rates, treatments and adverse effects.

    Philippe Tuppin, Solène Samson, Anne Fagot-Campagna, Bertrand Lukacs… in BMC Urology (2014)

    Download PDF (283 KB) View Article

  3. No Access

    Article

    Management of non-complicated BPH: proposition of a renewed decision tree

    Nowadays the management of benign prostatic hypertrophia (BPH) is undergoing striking changes. The standard medical treatments are represented by three families which are the phytotherapy, the alpha-blockers a...

    Francois Desgrandchamps, Alexandre de la Taille… in World Journal of Urology (2006)

  4. No Access

    Article

    Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxin

    The usual treatments of benign prostate hyperplasia (BPH) including the alpha-blockers, the inhibitors of the 5-alpha reductase and the phytotherapy drugs allow significant improvements of the lower urinary tr...

    Abdel-Rahmène Azzouzi, Marc Fourmarier, Francois Desgrandchamps… in World Journal of Urology (2006)